Association of Diabetes Care & Education Specialists

JOIN ADCES

AstraZeneca Educational Webinar Series

Presented by ADCES in association with AstraZeneca-US Medical Affairs, CVMD Division

This free educational webinar series is designed to provide the most up-to-date, cutting edge information in diabetes. Each webinar will be presented live and recorded. Archived presentations will be posted on this page for up to 90 days after the live broadcast, so don't miss out!

This webinar series is educational in nature and contains no promotional or product information. CE credit is not available.





Upcoming Webinars:

Stay tuned for 2022 dates!
    
  


Webinar Recordings

  

Bridging the Gap: Disparities in Heart Failure Associated with T2D: An Opportunity to Improve Care in the African American Community

Originally presented on September 8, 2021 by Crisamar J. Anunciado, PhD, FNP-BC, BC-ADM and Shamera Robinson, MPH, RDN, CDCES

The goal of this presentation is to tackle disparities and challenges that African American communities face by identifying key areas that can be addressed to bring change.

Upon completion of this activity, participants will be able to:

  1. Review health disparities and explore the causes of disparities among African American patients.
  2. Discuss health disparities in cardiovascular diseases including hypertension, heart failure, diabetes and chronic kidney disease among African American patients.
  3. Address the unmet need and raise awareness for patients and HCPs of African Heritage regarding the effects of cardiovascular diseases in the community.
                    
     
     

Impact of NAFLD and NASH and Emerging Treatment Approaches

Originally presented on November 10, 2021 by Paul Tomasic, MD, MS, FACP, FACE and Anne Misher, PharmD, MBA, BCACP, BC-ADM, CDCES

Upon completion of this activity, participants will be able to:

  1. Understand the pathophysiology of NAFLD/NASH and the associated risk factors and disease complications
  2. Describe the national prevalence and disease burden of NAFLD/NASH
  3. Discuss the typical clinical presentation and diagnostic recommendations for patients with NAFLD/NASH
  4. Summarize current and evolving treatment options for patients with NAFLD/NASH